Stifel Nicolaus Trims Andlauer Healthcare Group (TSE:AND) Target Price to C$52.00

Andlauer Healthcare Group (TSE:ANDFree Report) had its target price lowered by Stifel Nicolaus from C$55.00 to C$52.00 in a research note issued to investors on Monday, BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.

Several other research firms have also commented on AND. Royal Bank of Canada decreased their price target on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a sector perform rating for the company in a research report on Monday. Scotiabank lifted their price objective on shares of Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the stock a sector perform rating in a research note on Thursday, March 7th. Eight Capital cut their price objective on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating on the stock in a report on Thursday, March 7th. TD Securities decreased their price objective on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating for the company in a report on Monday. Finally, CIBC increased their price target on Andlauer Healthcare Group from C$50.00 to C$52.00 and gave the stock an outperform rating in a research report on Thursday, March 7th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Andlauer Healthcare Group presently has a consensus rating of Moderate Buy and a consensus target price of C$49.43.

Check Out Our Latest Analysis on Andlauer Healthcare Group

Andlauer Healthcare Group Price Performance

Shares of Andlauer Healthcare Group stock opened at C$40.51 on Monday. Andlauer Healthcare Group has a 12 month low of C$36.76 and a 12 month high of C$48.80. The company has a current ratio of 2.52, a quick ratio of 1.66 and a debt-to-equity ratio of 27.24. The stock has a 50 day moving average of C$42.10 and a 200 day moving average of C$40.51. The firm has a market cap of C$789.13 million, a PE ratio of 26.14 and a beta of 0.69.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last announced its earnings results on Tuesday, March 5th. The company reported C$0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.49 by C($0.05). The business had revenue of C$169.07 million for the quarter, compared to analysts’ expectations of C$165.00 million. Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. On average, research analysts expect that Andlauer Healthcare Group will post 1.8439434 EPS for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Thursday, March 28th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date was Wednesday, March 27th. This is a positive change from Andlauer Healthcare Group’s previous quarterly dividend of $0.09. Andlauer Healthcare Group’s payout ratio is currently 23.23%.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Recommended Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.